Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Humana Inc.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Climb Bio (CLYM), Humacyte (HUMA) and Phathom Pharma...

Analysts Offer Insights on Healthcare Companies: Climb Bio (CLYM), Humacyte (HUMA) and Phathom Pharmaceuticals (PHAT)

The SPDR S&P 500 ETF Trust ($SPY) gained 0.39% today, May 22, due to lower Treasury yields, hope for progress in U.S.-Iran talks, and strong corpor...

SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/22/2026

The latest announcement is out from Humana AB ( ($SE:HUM) ). Humana AB and Samhällsbyggnadsbolaget i Norden have agreed to sell an elderly care hom...

Humana Sells Elderly Care Property to Cut Debt and Refocus Capital

The SPDR S&P 500 ETF Trust ($SPY) gained 0.2% today, May 21, as falling oil and energy prices eased inflation worries. Hopes for progress in U.S.-I...

SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/21/2026

The SPDR S&P 500 ETF Trust ($SPY) gained 1.02% today, May 20, breaking a third-day losing streak, helped by lower oil prices, falling Treasury yiel...

SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/20/2026

The SPDR S&P 500 ETF Trust ($SPY) declined 0.67% today, May 19, its third straight day of losses. The drop came as Treasury yields jumped, inflatio...

SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/19/2026

A federal judge in Delaware has allowed significant portions of a securities fraud lawsuit against Humana (HUM) and certain former executives to pr...

Humana Securities Lawsuit Against Humana Partially Survives Motion to Dismiss 

The SPDR S&P 500 ETF Trust ($SPY) declined 1.2% today, May 15, as tech stocks pulled back from overbought levels, oil and energy prices jumped, Tre...

SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/15/2026

The SPDR S&P 500 ETF Trust ($SPY) rose 0.79% today, May 14. The gain was driven by a rebound in AI stocks, upbeat sentiment about the U.S.-China su...

SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/14/2026

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cullinan Management (CGEM), Humacyte (HUMA) and Revvity (RVTY). C...

Analysts Conflicted on These Healthcare Names: Cullinan Management (CGEM), Humacyte (HUMA) and Revvity (RVTY)

The SPDR S&P 500 ETF Trust ($SPY) rose 0.56% today, May 13, as a strong rebound in AI and semiconductor stocks outweighed hotter-than-expected infl...

SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/13/2026

An announcement from Humm Group Limited ( ($AU:HUM) ) is now available. Humm Group Limited has released the voting outcomes from its Extraordinary ...

Humm Group investors reject director removal bids at EGM

A federal judge has allowed part of the investor lawsuit against Humacyte, Inc. (HUMA) to proceed, finding that shareholders plausibly alleged misl...

Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive 

In a report released today, Lisa Gill from J.P. Morgan maintained a Hold rating on Humana, with a price target of $214.00. Gill covers the Healthca...

Humana (HUM) Gets a Hold from J.P. Morgan

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cartesian Therapeutics (RNAC) and Humana (HUM). Ca...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cartesian Therapeutics (RNAC) and Humana (HUM)

The SPDR S&P 500 ETF Trust ($SPY) gained 0.96% today, April 30. Positive earnings reports from some major companies, including Alphabet ($GOOGL), h...

Why Is SPDR S&P 500 ETF Trust (SPY) Up Today, 4/30/2026?

The SPDR S&P 500 ETF Trust ($SPY) declined 0.02% today, April 29, as investors weighed big earnings reports, rising energy prices from geopolitical...

Why Is the SPY ETF Down Today, 4/29/2026?

Humm Group Limited ( ($AU:HUM) ) just unveiled an announcement. Humm Group Limited has provided an update on its extraordinary general meeting, whi...

Humm Group further delays EGM under Takeovers Panel orders

Top AI talent and senior executives are leaving big tech firms like Meta Platforms ($META), Google ($GOOGL), and OpenAI to start their own companie...

Current Quarter	$5.75	Next Quarter	$-0.09
Current Year	$9.01	Next Year	$14.9
QoQ Growth	-101.6%	YoY Growth	+65.4%
3Y EPS CAGR	N/A	Target Price	$254.09
Consensus	Buy	Upside	-15.8%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HUM	$301.69	-2.03%	697.90K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HUM	$301.69	-2.0%	697.90K
3
4
5
6

HUM

HUM

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get Humana Inc. Data in Excel

Get Humana Inc. Data in Excel